KLAS Contact
Contact KLAS
Contact KLAS
2026 BEST IN KLAS
Preferences
Related Series
2025
2024
2023
2015
Related Segments
Global HIT Trends 2026
The AI Surge Continues
Author
Eder Lagemann
Author
Sidney Tate
The last two years have seen rapid advancements in AI technology, which has risen to the top of many healthcare organizations’ IT priority lists as they seek to ease pressures caused by staffing shortages, budget constraints, and a growing demand for care services. This fourth annual report on global healthcare IT (HIT) investment priorities leverages insights from 182 healthcare organizations across 43 countries and territories outside the US to detail the prevalence of AI as an organizational priority, its impact on other IT investment areas, and the additional technologies organizations are prioritizing amid market pressures. The report also discusses which technologies are generating the most excitement in the market, what organizations’ plans are for leveraging the cloud, and how they plan to engage consulting firms going forward.
If you don't have a login, getting started is easy.
Key Findings:
- AI Solidified as Top Investment Priority Around the World
- EHR/Digitalization & Imaging Investments Remain Foundational Clinical Priorities
- Infrastructure & Cybersecurity Still Top of Mind for Supporting Technology Advancements
- Cloud Adoption Accelerates as Organizations Move from Planning to Deployment
- Microsoft Azure Maintains Highest Mindshare as Interest in Private Cloud Declines
- Organizations Becoming More Selective About Consulting Engagements amid Economic Pressure
Writer
Elizabeth Pew
Designer
Kath Spencer
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2026 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.